Cardurion logo - click to return to the homepage

Cardurion Pharmaceuticals Announces Investment of up to $300 Million from Bain Capital

Investment to support Cardurion’s further evolution into a cardiovascular leader BOSTON – October 27, 2021 – Cardurion Pharmaceuticals, Inc. (“Cardurion” or “the Company”), a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced it has received a private investment […]

This site uses cookies and third-party scripts to provide certain services. View Privacy Policy

Skip to content